Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,684,188,978
New position
Shares Held
23,751,085
first reported quarter
Ownership
1.53%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 92.88699021539438.ToString("F0")%
None 7.11300978460563.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $38,477,015,517 across 12 Drug Manufacturers - General names. AZN ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,427,061 | $12,349,807,890 | |
| 2 | MRK |
Merck & Co., Inc.
|
84,314,971 | $10,142,247,857 | |
| 3 | JNJ |
Johnson & Johnson
|
20,075,375 | $4,907,224,662 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
23,751,085 | $4,684,188,978 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,537,991 | $1,886,789,800 | |
| 6 | ABBV |
AbbVie Inc.
|
6,897,816 | $1,500,205,997 | |
| 7 | PFE |
Pfizer Inc
|
49,916,961 | $1,401,668,262 | |
| 8 | GSK |
GSK plc
|
11,717,613 | $646,695,059 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,684,188,978 | 23,751,085 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||